FILTER

FILTERED INTERVIEW RESULTS

Trevor Caswell

CHAIRMAN, PHARMA.AERO

"Pharma.Aero is a unique collaborative platform connecting life sciences shippers and service providers to achieve reliable end-to-end air transport for pharmaceutical cargo."

United States

Pharma & Life Sciences

Denise Juliano

GROUP VICE PRESIDENT, LIFE SCIENCES, PREMIER INC.

"Our technology and data capabilities help researchers and providers gain insights into health inequities and support strategies and solutions to advance health equity."

United States

Pharma & Life Sciences

Cory Lewis

CEO, PRESIDENT AND CO-FOUNDER, INCOG BIOPHARMA SERVICES

"Wrapping up Q1 in 2023 we are now above 80 employees with a facility that is cGMP production ready and actively manufacturing commercial PPQ batches for one of our biopharma clients."

Petrochemicals & Chemicals

Aaron Montgomery

PRESIDENT AND CEO, OURAY

"Among our customers, we note a heightened awareness of preventative safety practices. Also, OURAY see a lot of growth in those exceedingly hazardous chemicals such as fluoridated and brominated materials."

United States

Pharma & Life Sciences

Katrin Rupalla

CEO, YMMUNOBIO

"Based on our in vivo data for our lead CEACAM1/5 antibody YB-200, we have obtained orphan drug status from FDA for the treatment of liver cancer."

United States

Pharma & Life Sciences

Stefan Randl & Paul Spencer

HEAD OF DRUG SUBSTANCE (SR), HEAD OF DRUG DELIVERY & PRODUCT (PS), EVONIK HEALTH CARE

"The US leads innovation, so if you are not heavily invested there in pharma, you are in trouble. Lots of our clients are shifting their production from Asia, so the US will remain critical to Evonik Health Care’s growth."

United States

Pharma & Life Sciences

Roger Erickson

CEO AND FOUNDER, INTERBIOME

"We want to pioneer a commodity utility approach for needed areas of pharmaceutical manufacturing, and make that available as a sustainable platform that any country can start with and innovate from."

United States

Pharma & Life Sciences

Jan Kengelbach

CEO, AENOVA GROUP

"Experienced CDMOs can provide companies with access to new formulation and technology methods that improve the bioavailability of difficult-to-formulate compounds."

United States

Pharma & Life Sciences

Donna LaVoie

PRESIDENT AND CEO, LAVOIEHEALTHSCIENCE

"Companies should be ready to address hostile short-selling and unsolicited takeover bids, develop rapid responses to special meetings and activist demands, and vigorously engage with institutional shareholders, proxy advisory firms, and potential regulators."

United States

Pharma & Life Sciences

Daniel Prince

CEO, PRINCE STERILIZATION SERVICES

"The expansion will allow Prince to more than double its headcount, increase manufacturing capacity, and offer additional ready-to-use products and sterilization services to the market."